GlassScriptPhysician profile
Linda J Ducat
NPI 1528133683
$1,626.93
in general payments reported to CMS, 2019-2025
15 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $114 · 2023: $529 · 2024: $869 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $613.42 | 2022-2025 | |
| Nevro Corp. | $248.97 | 2023-2024 | Senza |
| Averitas Pharma INC. | $208.30 | 2023-2024 | Qutenza |
| Neurelis, INC. | $124.99 | 2024 | Valtoco |
| Collegium Pharmaceutical, INC. | $102.53 | 2022-2024 | Belbuca, Xtampza |
| Teva Pharmaceuticals USA, INC. | $62.84 | 2023-2025 | Ajovy |
| Fidia Pharma USA INC. | $56.44 | 2024 | Hymovis |
| Biohaven Pharmaceutical Holding Company LTD. | $49.12 | 2022 | |
| Vertos Medical, INC. | $31.98 | 2023-2024 | Mild Device Kit |
| Lundbeck LLC | $30.21 | 2023 | Vyepti |
| Pfizer INC. | $23.14 | 2023 | |
| Allergan, INC. | $22.53 | 2022 | |
| Orexo US, INC. | $19.60 | 2025 | Zubsolv |
| Painteq LLC | $19.16 | 2024 | Painteq |
| Lilly USA, LLC | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Ducat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.